Skip to Main Content

Paper Details

A meta-analysis of epitopes in prostate-specific antigens identifies opportunities and knowledge gaps.
Hum Immunol
0
2023
B cell, B/T cell receptor, Cancer, DRB1*01, DRB1*01:01, HLA-, HLA-A*02:01, IFNg, ImmunomeBrowser, MHC, MHC ligand, MHC ligand epitopes, T cell, cancer, epitope, epitopes, immunodominant regions, prostate, prostate cancer, prostate-specific (PS) antigens, tumor
Author NameAffiliation
Bjoern PetersCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), University of California, San Diego (university of california san diego)
Bjoern PetersCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), University of California, San Diego (university of california san diego)
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), University of California, San Diego (university of california san diego)
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), University of California, San Diego (university of california san diego)
  • 1 - 4

Datasets

Dataset
Description
Source Link
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
CEDARCancer Epitope Database and Analysis ResouceLink
Release 1.2